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OBJECTIVES: Subclinical atherosclerosis has been recently detected in adolescents with a family history of
premature atherosclerosis. However, no studies in the literature have assessed the cardiac autonomic functions
of these adolescents. The aim of this study was to evaluate the cardiac autonomic functions of adolescents with
a family history of premature atherosclerosis compared with those of age- and gender-matched adolescents
without a family history of atherosclerosis.
METHOD: We evaluated the cardiac autonomic functions of 36 adolescents with a family history of premature
atherosclerosis (Group 1) and compared them with those of 31 age- and gender-matched adolescents whose
parents did not have premature atherosclerosis (Group 2). Twenty-four-hour time domain (standard deviation
of all normal sinus RR intervals [SDNN], standard deviation of the mean of normal RR intervals in each 5-minute
segment [SDANN], root-mean-square differences in successive RR intervals) and frequency domain (very low
frequency, low frequency, high frequency, low frequency/high frequency) parameters of heart rate variability
were used for the evaluation of cardiac autonomic functions.
RESULTS: There were no differences in the time and frequency domain parameters of heart rate variability
between the two groups. Heart rate was negatively correlated with SDNN (r = -0.278, p=0.035), while age was
significantly correlated with root-mean-square differences in successive RR intervals, high frequency, low
frequency and low frequency/high frequency (r = -0.264, -0.370, 0.265 and 0.374, respectively; p,0.05 for all).
CONCLUSION: We found that the cardiac autonomic functions of adolescents with a family history of
premature atherosclerosis were not different compared with those of adolescents without a positive family
history of premature atherosclerosis. It appears that subclinical atherosclerosis does not reach a critical value
such that it can alter cardiac autonomic functions in adolescence.
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& INTRODUCTION
Atherosclerosis (1) begins in childhood and atherosclero-
tic plaques (2) have been observed in coronary arteries
during adolescence. A family history of premature athero-
sclerosis (3) creates an additive effect in this process and
significantly increases the risk of developing atherosclerosis.
Complementary to these findings, subclinical atherosclero-
sis in adolescents with a family history of premature
atherosclerosis (4) has been recently demonstrated using
noninvasive techniques. However, the effect of subclinical
atherosclerosis on cardiac autonomic functions in these
adolescents has not yet been evaluated.
Heart rate variability (HRV) analysis (5) is a useful tool for
assessing cardiac autonomic functions. It has been used as a
predictor of sudden cardiac death and as a marker of
cardiovascular disease progression (6) in several high-risk
populations. The main objective of this study was to evaluate
the cardiac autonomic functions of adolescents with a family
history of premature atherosclerosis compared with those of
age- and gender-matched adolescents without a family
history of premature atherosclerosis using HRV analysis.
& MATERIALS AND METHODS
The coronary angiography records of Tepecik Training
and Research Hospital collected between May 1, 2012 and
Copyright  2014 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.




May 1, 2013, were examined. We conducted phone inter-
views with patients who had undergone coronary angio-
graphy for atherosclerosis at an early age (males ,45 years,
females ,55 years) during this period. The adolescent
children of these patients were included in the study. The
angiograms of the parents of the study participants were
visually reviewed. Obstructive coronary artery disease
(CAD) was defined as at least one epicardial coronary
lesion.2 mm in length resulting in a.50% narrowing in
diameter. Of the 59 patients who could be reached, five had
no children and six declared that their children could not
participate in the study for nonmedical reasons. The
exclusion criteria were congenital heart disease, moderate-
to-severe valvular heart disease, heart conduction disorders,
branch block, hypertension, diabetes mellitus, asthma, liver
or renal insufficiency, malignancy, smoking, or antiarrhyth-
mic drug therapy. One adolescent with a secundum-type
atrial septal defect and one with diabetes mellitus were
excluded from the study. The remaining 36 adolescents
(n = 25, males = 12) whose parents had CAD based on
coronary angiography constituted Group 1; 31 adolescents
(n = 23, males = 11) whose parents did not have CAD based
on coronary angiography constituted Group 2.
Anthropometric measurements (weight, height, waist and
hip circumferences) were performed using a standardized
technique and the body mass index (BMI) was calculated by
dividing the participant’s weight in kilograms by the square
of his/her height in meters. Systolic and diastolic blood
pressures were measured twice by one investigator with the
auscultation method using an appropriately sized cuff after
the patient had been seated quietly with his or her back
supported, feet on the floor and right arm supported for five
minutes. The blood biochemistry records of the study
participants in the last year, including complete blood
count, serum urea, creatinine, liver enzymes, fasting blood
glucose, lipid profile, uric acid, erythrocyte sedimentation
rate (ESR) and C-reactive protein (CRP) were used.
Twenty-four-hour Holter recordings obtained from
Group 1 and Group 2 were downloaded onto a computer
and analyzed with a Holter program (Norav Medical,
Version DL 800, 2006, Wiesbaden, Germany). All recordings
were also examined visually and artifacts were deleted
manually. All of the recordings had at least 22 hours of data
after removing the artifacts. The HRV parameters were
calculated using a computer and were statistically analyzed.
The time and frequency domain HRV parameters used in
this study were chosen according to the guidelines of the
European Society of Cardiology and the North American
Society of Pacing and Electrophysiology (7). The time
domain parameters included the standard deviations of all
normal sinus RR intervals over 24 hours (SDNN), standard
deviations of the mean of normal RR intervals for each 5-
minute segment (SDANN) and root-mean-square differ-
ences in successive RR intervals (RMSSD). Frequency
domain parameters included low frequency (LF), high
frequency (HF) and very low frequency (VLF) components
and the LF/HF ratio. Frequency domain analysis was
performed using a non-parametric Fast Fourier transform
(FFT)-based method.
All the subjects were recorded under fairly similar
conditions and in a fairly similar environment. They were
asked not to consume tea, coffee, chocolate, or alcohol-
containing substances for at least eight hours before and
during the entire Holter recording period. They were asked
to try and maintain normal behaviors and activities.
Ethics
The present study was a single-center study. All
examinations were performed at the Department of
Cardiology of Tepecik Training and Research Hospital. All
subjects provided informed consent prior to inclusion in the
study. The study protocol was approved by the Ethics
Committee of Tepecik Training and Research Hospital.
Statistical analysis
Statistical analysis was performed using SPSS for
Windows, version 15.0 (SPSS Inc., Chicago, IL, USA).
According to the Kolmogorov-Smirnov test, all of the
continuous variables were normally distributed. To analyze
the continuous data, a two-tailed independent samples t-test
was used and the data were expressed as the mean ¡
standard deviation (SD). A chi-square test was used to
analyze the categorical data and the data were expressed as
percentages. To define correlations between age, heart rate
and HRV measures, Pearson’s correlation analysis was
applied. P-values ,0.05 were considered statistically sig-
nificant.
& RESULTS
There were no significant differences between Group 1
and Group 2 with regard to age, gender, BMI, waist
circumference, systolic and diastolic blood pressures, fast-
ing blood glucose, uric acid, lipid profile, ESR, CRP,
hemoglobin or white blood cell counts (Table 1).
Basal heart rate was found to be higher in Group 1, but
this difference did not reach significance (p= 0.061). Neither
time nor frequency domain measures were found to be
significantly different between the two groups (Table 2).
There were no differences in HRV measures with regard to
gender between the groups. Heart rate was negatively
correlated with SDNN (r = -0.278, p= 0.035), while age was
significantly correlated with RMSSD, HF, LF, and LF/HF
(r = -0.264, -0.370, 0.265 and 0.374, respectively; p,0.05 for
all) (Figure 1).
& DISCUSSION
The major finding of this study was that the HRV
parameters of adolescents with a family history of pre-
mature atherosclerosis are not different from those of
adolescents without a family history of premature athero-
sclerosis. We initially hypothesized that if adolescents with
a family history of premature atherosclerosis have sub-
clinical atherosclerosis, as shown previously, their cardiac
autonomic functions may be altered. However, our findings
did not confirm this hypothesis. There may be several
explanations for this finding. First, the degree of athero-
sclerosis in the adolescents with subclinical atherosclerosis
may not reach a threshold such that cardiac autonomic
functions are affected during the adolescent period. Because
HRV has been shown to be deteriorated in adult patients
with CAD and has been correlated with disease duration
(8), it is logical to assume that cardiac automaticity is not yet
affected in the early stages of atherosclerosis during
adolescence. Second, the adolescents with a positive family
history of atherosclerosis in our study may not have actually
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had subclinical atherosclerosis. Because we did not utilize
noninvasive assessment tools for the evaluation of sub-
clinical atherosclerosis in this group, we were unable to
determine whether subclinical atherosclerosis was present.
However, Celik et al. (4) demonstrated subclinical athero-
sclerosis in adolescents whose fathers had a history of
premature CAD based on the carotid stiffness index, carotid
intima-media thickness and pulse wave velocity.
The autonomic nervous system can be affected by the risk
factors that cause CAD. The adolescents in Group 1 in our
study had no risk factors other than a family history.
However, elevation of inflammatory markers (4) leading to
subclinical atherosclerosis was previously identified in a
similar study population. Several studies evaluated the
interaction of inflammation with the autonomic nervous
system. In general, these studies (9-11) demonstrated
significant associations between the elevated burdens of
systemic inflammation and reduced mean levels of HRV.
The initial step or trigger for this interaction may be either
inflammation or autonomic nervous system dysfunction;
however, this point is still debated. Banks et al. (12) and
Goehler et al. (13) demonstrated the activation of sympa-
thetic outflow secondary to elevated systemic inflammation
in different studies. Additionally, middle-aged individuals
with elevated inflammatory markers (14) were found to
have lower HRV measures and elevated systemic inflam-
mation has been hypothesized to result in deterioration of
cardiac autonomic functions. However, several experimen-
tal and laboratory studies (15,16) have demonstrated that
autonomic imbalance is the primary event leading to the
activation of inflammation because the bone marrow and
lymphoreticular system are innervated by autonomic
nerves. In addition, sympathectomy, whether surgical or
medical (17-18), alters and reduces the inflammatory
reaction. We believe that our study is consistent with
studies demonstrating that inflammation is the initial event
leading to atherosclerosis. Because there was no deteriora-
tion of HRV measures in adolescents suspected to have
subclinical atherosclerosis in our study. Based on these
findings, it is plausible that the degree of inflammation and
atherosclerosis are the determinants of deterioration in
HRV. In adolescence, the threshold for the deterioration of
HRV does not appear to be reached. We believe that
comprehensive studies should be performed to investigate
the interaction of inflammation and HRV in adolescence,
especially among individuals with a family history of
atherosclerosis.
HRV is a generally accepted tool for the assessment of
cardiac autonomic functions. Reduction of HRV is a sign of
cardiac autonomic imbalance and is associated with an
increase in mortality. Although most HRV studies have been
performed in adult populations, HRV has also been studied
in children and adolescents. HRV is usually assessed with
time and frequency domain analyses using short- and long-
term recordings. The disadvantage of short-term recordings
is their failure to detect long-term trends in diurnal influences
on heart rate. Clinical studies in children and adolescents
where good cooperation can be difficult predominantly
utilize 24-hour time domain analysis. HRV studies in
children and adolescents have often revealed that HRV
measures changed with age and were related to gender. In
contrast to adults, HRV measures tend to be increased in
children and older adolescents (19-21). However, in our
study, with increasing age, RMSSD and HF measures
decreased in contrast to the trend of LF and LF/HF, reflecting
decreased parasympathetic modulation. Our findings were
consistent withHRV studies in adult populations, whichmay
Table 2 - Time and frequency domain parameters of the
two groups.
Variables Group 1 (n= 36) Group 2 (n= 31) p-value
SDNN (ms) 159.09¡32.72 162.35¡41.88 0.733
SDANN (ms) 108.53¡70.67 132.49¡91.48 0.251
RMSSD (ms) 77.24¡35.10 74.35¡40.24 0.763
VLF (ms2) 288.37¡39.14 297.90¡62.58 0.472
LF (ms2) 173.73¡32.01 186.92¡31.47 0.107
HF (ms2) 149.0¡32.72 143.50¡34.40 0.521
LF/HF 1.23¡0.41 1.40¡0.48 0.147
HR (/min) 83.88¡8.81 79.66¡8.98 0.061
SDNN: standard deviation of all normal sinus RR intervals; SDANN:
standard deviation of the mean of normal RR intervals in each 5-minute
segment; RMSSD: root-mean-square differences in successive RR intervals;
VLF: very low frequency; LF: low frequency; HF: high frequency; HR: heart
rate. The data are shown as the mean¡SD.
Table 1 - Baseline characteristics and laboratory findings of the study groups.
Variables Group 1 (n= 36) Group 2 (n= 31)) p-value
Age, mean (years) 14.0¡1.9 14.8¡1.8 0.091
Gender (F) (%) 19 (52) 21(67) 0.112
BMI (kg/m2) 21.5¡4.3 20.9¡3.0 0.529
Waist circumference (cm) 73.4¡12.5 72.0¡10.1 0.689
Systolic BP (mmHg) 106.8¡14.1 109.8¡10.5 0.342
Diastolic BP (mmHg) 65.2¡9.8 67.4¡9.8 0.378
Fasting glucose (mg/dL) 88.4¡10.2 87.5¡7 0.749
Uric acid (mg/dL) 4.3¡1.10 3.9¡1.07 0.326
Total cholesterol (mg/dL) 162.8¡25.0 151.4¡23.0 0.134
Triglycerides (mg/dL) 99.7 ¡ 19.4 82.2¡65.2 0.363
LDL-C (mg/dL) 93.7¡19.4 85.1¡21.3 0.187
HDL-C (mg/dL) 49¡8.6 49¡12.1 0.938
WBC (x103/mL) 7.1¡1.5 7.2¡1.8 0.798
Hemoglobin (g/dl) 13.6¡1.0 12.7¡1.7 0.062
ESR (mm/h) 7.0¡4.1 7.9¡3.2 0.556
CRP (mg/L) 0.5¡0.2 0.4¡0.1 0.721
BMI: body mass index; BP: blood pressure; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; WBC: white blood cell
count; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.
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be due to the lack of children in our study and the maturation
of the autonomic nervous system during adolescence.
In adolescents, HRV was also evaluated in diseases
known to affect cardiac autonomic functions in adulthood.
Wawryk et al. (22) reported that adolescents with type 1
diabetes have decreased HRV measures compared with
healthy controls. Additionally, poor glycemic control and a
long duration of diabetes were found to be negatively
associated with HRV measures (23-24). Obese adolescents
(25) were found to have increased LF/HF values and lower
Figure 1 - Pearson correlation analysis of the following variables: heart rate and SDNN (A), age and RMSSD (B), age and HF (C), age and
LF (D) and age and LF/HF (E). SDNN: standard deviation of all normal sinus RR intervals; RMSSD: root-mean-square differences in
successive RR intervals; LF: low frequency; HF: high frequency.
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SDNN values, indicating an imbalance in the sympathetic
activity of the heart. It has previously been shown that HRV
is decreased in adult patients with CAD. However, until
now, there have been no data available regarding whether
subclinical atherosclerosis in adolescents alters HRV or the
age range in which it begins to cause HRV deterioration. To
our knowledge, this is the first study evaluating HRV in
adolescents with a family history of premature athero-
sclerosis. Because subclinical atherosclerosis has been
shown before in this population, we chose to investigate
the HRV measures in this population.
The main limitation of our study is the small sample size.
Because a small sample size results in low statistical power
for equivalency testing, the negative results may simply be
due to chance. Another limitation of our study is the fact
that we accepted the study group as having subclinical
atherosclerosis based on a recent study, as well as the lack of
evaluation of subclinical atherosclerosis. Finally, we eval-
uated the inflammation level in the two groups based only
on ESR and CRP levels and found no difference. The use of
highly specific inflammatory markers for atherosclerosis,
such as high-sensitivity CRP and homocysteine values,
would be preferable.
In conclusion, the time and frequency domain HRV
measures of adolescents with a family history of premature
atherosclerosis were not different from those of adolescents
without a family history of atherosclerosis. The level of
subclinical atherosclerosis in adolescents does not reach a
critical value that would result in deterioration of the
cardiac autonomic functions during this stage. We believe
that prospective studies with more participants should be
conducted in adolescents and young adults to facilitate the
observation of atherosclerosis maturation and the stage-by-
stage effect of this process on cardiac autonomic functions.
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